drugset / Trial / NCT07036250
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open-label clinical study to evaluate the safety, tolerability, and efficacy of U32 injection in patients with acute myeloid leukemia.
Timeline
- Start
- 2025-07-03
- Primary completion
- 2027-12-31
- Completion
- 2029-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | U32 | Unknown | — | — |